JP2020522560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020522560A5 JP2020522560A5 JP2019567995A JP2019567995A JP2020522560A5 JP 2020522560 A5 JP2020522560 A5 JP 2020522560A5 JP 2019567995 A JP2019567995 A JP 2019567995A JP 2019567995 A JP2019567995 A JP 2019567995A JP 2020522560 A5 JP2020522560 A5 JP 2020522560A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- composition
- subject
- over
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023030625A JP2023071826A (ja) | 2017-06-06 | 2023-03-01 | 過活動膀胱を治療するためのビベグロンの使用 |
| JP2025005498A JP2025063196A (ja) | 2017-06-06 | 2025-01-15 | 過活動膀胱を治療するためのビベグロンの使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762515996P | 2017-06-06 | 2017-06-06 | |
| US62/515,996 | 2017-06-06 | ||
| US201862635146P | 2018-02-26 | 2018-02-26 | |
| US62/635,146 | 2018-02-26 | ||
| US201862637961P | 2018-03-02 | 2018-03-02 | |
| US62/637,961 | 2018-03-02 | ||
| PCT/IB2018/054069 WO2018224989A1 (en) | 2017-06-06 | 2018-06-06 | Use of vibegron to treat overactive bladder |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023030625A Division JP2023071826A (ja) | 2017-06-06 | 2023-03-01 | 過活動膀胱を治療するためのビベグロンの使用 |
| JP2025005498A Division JP2025063196A (ja) | 2017-06-06 | 2025-01-15 | 過活動膀胱を治療するためのビベグロンの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020522560A JP2020522560A (ja) | 2020-07-30 |
| JP2020522560A5 true JP2020522560A5 (enExample) | 2021-07-26 |
| JP7682605B2 JP7682605B2 (ja) | 2025-05-26 |
Family
ID=62815097
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567995A Active JP7682605B2 (ja) | 2017-06-06 | 2018-06-06 | 過活動膀胱を治療するためのビベグロンの使用 |
| JP2023030625A Pending JP2023071826A (ja) | 2017-06-06 | 2023-03-01 | 過活動膀胱を治療するためのビベグロンの使用 |
| JP2025005498A Pending JP2025063196A (ja) | 2017-06-06 | 2025-01-15 | 過活動膀胱を治療するためのビベグロンの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023030625A Pending JP2023071826A (ja) | 2017-06-06 | 2023-03-01 | 過活動膀胱を治療するためのビベグロンの使用 |
| JP2025005498A Pending JP2025063196A (ja) | 2017-06-06 | 2025-01-15 | 過活動膀胱を治療するためのビベグロンの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12102638B2 (enExample) |
| EP (2) | EP4410295A3 (enExample) |
| JP (3) | JP7682605B2 (enExample) |
| KR (2) | KR20250099259A (enExample) |
| CN (3) | CN117695287A (enExample) |
| AU (2) | AU2018282104B2 (enExample) |
| BR (1) | BR112019025636A2 (enExample) |
| CA (1) | CA3064989A1 (enExample) |
| CL (1) | CL2019003533A1 (enExample) |
| IL (2) | IL317220A (enExample) |
| MX (1) | MX2022015629A (enExample) |
| PH (1) | PH12019502651A1 (enExample) |
| WO (1) | WO2018224989A1 (enExample) |
| ZA (1) | ZA202000028B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7291632B2 (ja) * | 2017-12-21 | 2023-06-15 | 杏林製薬株式会社 | 夜間頻尿治療剤 |
| TW202038963A (zh) * | 2018-12-05 | 2020-11-01 | 瑞士商優洛凡特科學公司 | 維貝隆（ｖｉｂｅｇｒｏｎ）於治療患有良性前列腺增生之男性中膀胱過動症症狀之用途 |
| TW202506129A (zh) * | 2019-03-18 | 2025-02-16 | 瑞士商優洛凡特科學公司 | 維貝隆（ｖｉｂｅｇｒｏｎ）用於治療膀胱過動症之用途 |
| DE102020124101A1 (de) | 2020-02-04 | 2021-08-05 | Samsung Electronics Co., Ltd. | Elektronische vorrichtung mit einer speichervorrichtung und trainingsverfahren |
| AR124479A1 (es) | 2020-12-22 | 2023-03-29 | Urovant Sciences Gmbh | Métodos de monitoreo de la digoxina con el uso de vibegrón para el tratamiento de la vejiga hiperactiva |
| WO2025262600A1 (en) | 2024-06-17 | 2025-12-26 | Urovant Sciences Gmbh | Crystalline form of vibegron hemihydrate |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100506568B1 (ko) | 1997-10-17 | 2006-04-21 | 아스텔라스세이야쿠 가부시키가이샤 | 아미드유도체및이의염,및이를포함하는약제학적제제 |
| GB9812709D0 (en) | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| US6562375B1 (en) | 1999-08-04 | 2003-05-13 | Yamanouchi Pharmaceuticals, Co., Ltd. | Stable pharmaceutical composition for oral use |
| GB0015246D0 (en) * | 2000-06-22 | 2000-08-16 | Astrazeneca Ab | Method for the treatment of urinary incontinence |
| US6525202B2 (en) | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| US7342117B2 (en) | 2001-10-30 | 2008-03-11 | Astellas Pharma Inc. | α-form or β-form crystal of acetanilide derivative |
| DOP2003000587A (es) | 2002-02-27 | 2003-08-30 | Pfizer Prod Inc | AGONISTAS DEL RECEPTOR ß3-ADRENERGICO |
| CA2503570C (en) | 2002-11-07 | 2011-04-19 | Yamanouchi Pharmaceutical Co., Ltd. | Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| CA2524023C (en) | 2003-05-05 | 2011-11-22 | Kissei Pharmaceutical Co., Ltd. | Use of phenoxyacetic acid derivatives for treating hyperactive bladder |
| FR2874011B1 (fr) | 2004-08-03 | 2007-06-15 | Sanofi Synthelabo | Derives de sulfonamides, leur preparation et leur application en therapeutique |
| WO2008128968A1 (en) | 2007-04-19 | 2008-10-30 | Novartis Ag | Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
| KR101586503B1 (ko) | 2007-09-13 | 2016-01-18 | 코덱시스, 인코포레이티드 | 아세토페논의 환원을 위한 케토리덕타제 폴리펩티드 |
| SI2216021T1 (sl) | 2007-11-02 | 2013-01-31 | Astellas Pharma Inc. | Farmacevtski sestavek za zdravljenje prekomerno aktivnega sečnega mehurja |
| PE20091825A1 (es) | 2008-04-04 | 2009-12-04 | Merck & Co Inc | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 |
| SI2329014T1 (sl) | 2008-08-29 | 2015-01-30 | Codexis, Inc. | Polipeptidi ketoreduktaze za stereoselektivno produkcijo (4s)-3(5s)-5(4-fluorofenil)-5-hidroksipentanoil)-4-fenil-1,3-oksazolidin -2-ona |
| US20120202819A1 (en) | 2009-10-07 | 2012-08-09 | Merck Sharp & Dohme Corporation | Combination therapy using a beta 3 adrenergic receptor agonists and an antimuscarinic agent |
| CA2796877A1 (en) | 2010-04-30 | 2011-11-03 | Merck Sharp & Dohme Corp. | Novel beta 3 adrenergic receptor agonists |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| PE20131341A1 (es) | 2010-08-03 | 2013-12-07 | Altherx Inc | Combinaciones de agonistas del receptor beta-3-adrenergico y antagonistas del receptor muscarinico para tratar vejiga hiperactiva |
| US9522129B2 (en) | 2010-08-03 | 2016-12-20 | Velicept Therapeutics, Inc. | Pharmaceutical Combination |
| US9168254B2 (en) | 2011-10-14 | 2015-10-27 | Array Biopharma Inc. | Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing them |
| ES2584427T3 (es) | 2011-10-27 | 2016-09-27 | Merck Sharp & Dohme Corp. | Proceso para la preparación de agonistas beta 3 y productos intermedios |
| WO2013062881A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 agonists and intermediates |
| CN106479990B (zh) | 2011-11-18 | 2020-09-18 | 科德克希思公司 | 用于制备羟基取代的氨基甲酸酯的生物催化剂 |
| EP2606894A1 (en) | 2011-12-20 | 2013-06-26 | Sanofi | Novel therapeutic use of p75 receptor antagonists |
| UA112028C2 (uk) | 2012-12-14 | 2016-07-11 | Пфайзер Лімітед | Похідні імідазопіридазину як модулятори гамка-рецептора |
| JP6383403B2 (ja) | 2013-03-15 | 2018-08-29 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | β−３作動薬および中間体の製造方法 |
| MX2017007054A (es) | 2014-12-03 | 2018-05-02 | Velicept Therapeutics Inc | Composiciones y métodos para usar solabegron de liberación modificada para sintomas del tracto urinario inferior. |
| CN108290824B (zh) | 2015-10-23 | 2022-03-11 | B3Ar治疗股份有限公司 | 索拉贝隆两性离子及其应用 |
| WO2017210700A1 (en) | 2016-06-03 | 2017-12-07 | Velicept Therapeutics, Inc. | Compositions and methods of using modified release solabegron for lower urinary tract symptoms |
| WO2017210696A1 (en) | 2016-06-03 | 2017-12-07 | Velicept Therapeutics, Inc. | Dosing regimens for beta-3 adrenoceptor agonists and anti-muscarinic agents for the treatment and prevention of lower urinary tract symptoms and overactive bladder |
| CN110869053A (zh) | 2017-06-06 | 2020-03-06 | 乌洛万特科学有限公司 | 给药维贝隆以治疗膀胱过度活动症 |
| JP7291632B2 (ja) | 2017-12-21 | 2023-06-15 | 杏林製薬株式会社 | 夜間頻尿治療剤 |
| SG11202010683PA (en) | 2018-05-23 | 2020-12-30 | Urovant Sciences Gmbh | Use of vibegron to treat pain associated with irritable bowel syndrome |
| TW202038963A (zh) | 2018-12-05 | 2020-11-01 | 瑞士商優洛凡特科學公司 | 維貝隆（ｖｉｂｅｇｒｏｎ）於治療患有良性前列腺增生之男性中膀胱過動症症狀之用途 |
| TW202506129A (zh) | 2019-03-18 | 2025-02-16 | 瑞士商優洛凡特科學公司 | 維貝隆（ｖｉｂｅｇｒｏｎ）用於治療膀胱過動症之用途 |
| AR124479A1 (es) | 2020-12-22 | 2023-03-29 | Urovant Sciences Gmbh | Métodos de monitoreo de la digoxina con el uso de vibegrón para el tratamiento de la vejiga hiperactiva |
| TW202245781A (zh) | 2021-02-16 | 2022-12-01 | 瑞士商優洛凡特科學公司 | 用維貝格龍（ｖｉｂｅｇｒｏｎ）治療心臟衰竭之方法 |
-
2018
- 2018-06-06 KR KR1020257020007A patent/KR20250099259A/ko active Pending
- 2018-06-06 CN CN202311666478.3A patent/CN117695287A/zh active Pending
- 2018-06-06 AU AU2018282104A patent/AU2018282104B2/en active Active
- 2018-06-06 JP JP2019567995A patent/JP7682605B2/ja active Active
- 2018-06-06 KR KR1020197038625A patent/KR20200012949A/ko not_active Ceased
- 2018-06-06 BR BR112019025636-9A patent/BR112019025636A2/pt not_active Application Discontinuation
- 2018-06-06 IL IL317220A patent/IL317220A/en unknown
- 2018-06-06 CN CN202311666042.4A patent/CN117695286A/zh active Pending
- 2018-06-06 WO PCT/IB2018/054069 patent/WO2018224989A1/en not_active Ceased
- 2018-06-06 CN CN201880045540.8A patent/CN110869022A/zh active Pending
- 2018-06-06 US US16/620,179 patent/US12102638B2/en active Active
- 2018-06-06 CA CA3064989A patent/CA3064989A1/en active Pending
- 2018-06-06 EP EP24181939.0A patent/EP4410295A3/en active Pending
- 2018-06-06 EP EP18737031.7A patent/EP3634420A1/en not_active Withdrawn
-
2019
- 2019-11-25 PH PH12019502651A patent/PH12019502651A1/en unknown
- 2019-12-04 MX MX2022015629A patent/MX2022015629A/es unknown
- 2019-12-04 CL CL2019003533A patent/CL2019003533A1/es unknown
- 2019-12-04 IL IL271164A patent/IL271164A/en unknown
-
2020
- 2020-01-02 ZA ZA2020/00028A patent/ZA202000028B/en unknown
-
2023
- 2023-03-01 JP JP2023030625A patent/JP2023071826A/ja active Pending
-
2024
- 2024-07-03 AU AU2024204591A patent/AU2024204591A1/en active Pending
-
2025
- 2025-01-15 JP JP2025005498A patent/JP2025063196A/ja active Pending
- 2025-04-25 US US19/190,296 patent/US20260014158A1/en active Pending